Table 7. Enantiomeric preference of EU1794-27.
EC50 (µM) [conf. int.]* Maximal Modulation Extent (% of control) |
||||
---|---|---|---|---|
Compound | EU1794-27 | (-)-EU1794-27 | (+)-EU1794-27 | |
GluN2A | 7.4 [5.3, 10]†
52 ± 7% |
5.6 [2.7, 12] 67 ± 5% |
- | ‡ |
GluN2B | 1.4 [1.2, 1.7]†
130 ± 3% |
2.8 [2.0, 3.8] 170 ± 10% |
- | ‡ |
GluN2C | 2.8 [2.5, 3.2]†
230 ± 10% |
5.1 [4.1, 6.4] 260 ± 24% |
7.1 [3.6, 14] 160 ± 6.2% |
‡ |
GluN2D | 2.4 [1.8, 3.3]†
250 ± 8% |
8.2 [6.7, 9.9] 340 ± 21% |
7.4 [3.7, 15] 130 ± 4.7% |
‡ |
*EC50 values were obtained by least-squares fitting of data from individual experiments by the Hill equation. EC50 values are given as the mean with the 95% confidence interval determined from log(EC50); the maximal degree of modulation is given as mean ±SEM. Data are from 4 to 7 oocytes from at least two independent experiments. Data were not fitted (shown as -) if the response recorded at 30 µM of test compound did not differ by more than 15% from control.
†Data from Table 1 is included here for clarity.
‡indicates significant unpaired t-test between the percent modulation between 30 µM (-)-EU1794-27 and (+)-EU1794-27.